Jefferies Group’s Antares Pharma, Inc. ATRS Stock Holding History

Jefferies Group’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-135,000	Closed	-$539K	–	2124
2020 Q4	$539K	Buy	+135,000	New	+$437K	﹤0.01%	1110
2019 Q3	–	Sell	-53,000	Closed	-$174K	–	3166
2019 Q2	$174K	Sell	53,000 -172,000	-76%	-$498K	﹤0.01%	2181
2019 Q1	$682K	Buy	+225,000	New	+$729K	0.01%	1455
2018 Q3	–	Sell	-13,100	Closed	-$34K	–	2851
2018 Q2	$34K	Buy	+13,100	New	+$32.6K	﹤0.01%	2220
2017 Q2	–	Sell	-55,000	Closed	-$156K	–	2692
2017 Q1	$156K	Sell	55,000 -115,000	-68%	-$277K	﹤0.01%	2079
2016 Q4	$396K	Buy	+170,000	New	+$324K	﹤0.01%	1672

Other funds holding ATRS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

CWM

Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Jefferies Group's ATRS Position: Q1 2021 in Review

Jefferies Group sold out of Antares Pharma, Inc. (ATRS) in Q1 2021, closing a stake of 135,000 shares — an estimated $539K sold.

Jefferies Group first reported a position in ATRS in Q4 2016 and held it in 6 quarters. The position peaked at $682K in Q1 2019. 171 funds tracked by Wall St. Rank hold ATRS as of Q1 2021.

Jefferies Group reported no remaining Antares Pharma, Inc. position as of Q1 2021 after selling out during the quarter.
Jefferies Group sold 135,000 Antares Pharma, Inc. shares in Q1 2021, an estimated $539K.
Jefferies Group first reported a position in Antares Pharma, Inc. in Q4 2016 and held it in 6 quarters.
Jefferies Group's Antares Pharma, Inc. position peaked at $682K in Q1 2019.
171 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2021.

Based on Jefferies Group's 13F filing for Q1 2021, filed 14 May 2021.